Immunodiagnostic Systems Hldgs PLC Director/PDMR Shareholding (3443M)
January 07 2019 - 2:20AM
UK Regulatory
TIDMIDH
RNS Number : 3443M
Immunodiagnostic Systems Hldgs PLC
07 January 2019
Immunodiagnostic Systems Holdings plc
Director Dealing
07 January 2019
Immunodiagnostic Systems Holdings plc (IDH.L) ("IDS" or the
"Company"), a specialist producer of manual and automated
diagnostic testing kits and instrumentation for the clinical and
research markets, was advised that on Friday 4(th) January 2019, Dr
Peter Kaspar, Non-Executive Director, acquired 3,000 ordinary
shares of 2p each ("Ordinary Shares") in the Company at an average
price of GBP1.88 per Ordinary Share.
Following these purchases, Dr Kaspar is interested in 18,100
Ordinary Shares, 0.06% of the issued share capital of the
Company.
For further information:
Immunodiagnostic Systems Holdings Tel : +44 (0)191 519
plc 0660
Paul Martin, Group Finance Director
Peel Hunt LLP Tel : +44 (0)207 418
8900
James Steel
Oliver Jackson
Notification and public disclosure of transactions by persons
discharging
managerial responsibilities and persons closely associated with
them
1. Details of the person discharging managerial responsibilities
/ person closely associated
a. Name Peter Kaspar
------------------------------ -----------------------------------------------
2. Reason for the notification
-------------------------------------------------------------------------------
a. Position/status Non-Executive Director
------------------------------ -----------------------------------------------
b. Initial notification Initial
/Amendment
------------------------------ -----------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------------
a. Name Immunodiagnostic Systems Holdings plc
------------------------------ -----------------------------------------------
b. LEI 213800HZMYTD4NGF4L78
------------------------------ -----------------------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------------------
a. Description of Ordinary shares of 2p each in Immunodiagnostic
the Systems Holdings plc
Financial instrument, Ordinary shares
type of instrument GB00B01YZ052
Identification
code
------------------------------ -----------------------------------------------
b. Nature of the Purchase
transaction
------------------------------ -----------------------------------------------
c. Price(s) and Price(s) Volume(s)
volume(s) GBP1.88 3,000
----------
------------------------------ -----------------------------------------------
d. Aggregated information
* Aggregated volume N/A
* Price
------------------------------ -----------------------------------------------
e. Date of the transaction 2019-01-04
------------------------------ -----------------------------------------------
f. Place of the London Stock Exchange, AIM
transaction
------------------------------ -----------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHGIGDBIBGBGCR
(END) Dow Jones Newswires
January 07, 2019 03:20 ET (08:20 GMT)
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Apr 2023 to Apr 2024